Development of a Label-Free LC-MS/MS-Based Glucosylceramide Synthase Assay and Its Application to Inhibitors Screening for Ceramide-Related Diseases

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2018 Sep 21

PMID 30231605

Citations 1

Authors

Zhicheng Fu

So Yoon Yun

Jong Hoon Won

Moon Jung Back

Ji Min Jang

Hae Chan Ha

Hae Kyung Lee

In Chul Shin

Ju Yeun Kim

Hee Soo Kim

Dae Kyong Kim

Affiliations

Soon will be listed here.

Abstract

Ceramide metabolism is known to be an essential etiology for various diseases, such as atopic dermatitis and Gaucher disease. Glucosylceramide synthase (GCS) is a key enzyme for the synthesis of glucosylceramide (GlcCer), which is a main ceramide metabolism pathway in mammalian cells. In this article, we developed a liquid chromatography-tandem mass spectrometry (LCMS/MS) method to determine GCS activity using synthetic non-natural sphingolipid C8-ceramide as a substrate. The reaction products, C8-GlcCer for GCS, could be separated on a C18 column by reverse-phase high-performance liquid chromatography (HPLC). Quantification was conducted using the multiple reaction monitoring (MRM) mode to monitor the precursor-to-product ion transitions of m/z 588.6 → 264.4 for C8-GlcCer at positive ionization mode. The calibration curve was established over the range of 0.625-160 ng/mL, and the correlation coefficient was larger than 0.999. This method was successfully applied to detect GCS in the human hepatocellular carcinoma cell line (HepG2 cells) and mouse peripheral blood mononuclear cells. We also evaluated the inhibition degree of a known GCS inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) on GCS enzymatic activity and proved that this method could be successfully applied to GCS inhibitor screening of preventive and therapeutic drugs for ceramide metabolism diseases, such as atopic dermatitis and Gaucher disease.

Citing Articles

Mapping Sphingolipid Metabolism Pathways during Phagosomal Maturation.

Mehendale N, Mallik R, Kamat S ACS Chem Biol. 2021; 16(12):2757-2765.

PMID: 34647453 PMC: 7612119. DOI: 10.1021/acschembio.1c00393.

References

van Meer G, Holthuis J . Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta. 2000; 1486(1):145-70. DOI: 10.1016/s1388-1981(00)00054-8. View

Senchenkov A, Litvak D, Cabot M . Targeting ceramide metabolism--a strategy for overcoming drug resistance. J Natl Cancer Inst. 2001; 93(5):347-57. DOI: 10.1093/jnci/93.5.347. View

Sietsma H, Veldman R, Kok J . The involvement of sphingolipids in multidrug resistance. J Membr Biol. 2001; 181(3):153-62. DOI: 10.1007/s00232-001-0033-1. View

Duclos R . The total syntheses of D-erythro-sphingosine, N-palmitoylsphingosine (ceramide), and glucosylceramide (cerebroside) via an azidosphingosine analog. Chem Phys Lipids. 2001; 111(2):111-38. DOI: 10.1016/s0009-3084(01)00152-9. View

Vielhaber G, Pfeiffer S, Brade L, Lindner B, Goldmann T, Vollmer E . Localization of ceramide and glucosylceramide in human epidermis by immunogold electron microscopy. J Invest Dermatol. 2001; 117(5):1126-36. DOI: 10.1046/j.0022-202x.2001.01527.x. View

Di Sano F, Di Bartolomeo S, Fazi B, Fiorentini C, Matarrese P, Spinedi A . Antisense to glucosylceramide synthase in human neuroepithelioma affects cell growth but not apoptosis. Cell Death Differ. 2002; 9(6):693-5. DOI: 10.1038/sj.cdd.4401040. View

Kolesnick R . The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest. 2002; 110(1):3-8. PMC: 151041. DOI: 10.1172/JCI16127. View

Bleicher R, Cabot M . Glucosylceramide synthase and apoptosis. Biochim Biophys Acta. 2003; 1585(2-3):172-8. DOI: 10.1016/s1388-1981(02)00338-4. View

Liu Y, Han T, Yu J, Bitterman A, Le A, Giuliano A . Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells. J Lipid Res. 2004; 45(5):933-40. DOI: 10.1194/jlr.M300486-JLR200. View

10.

Degroote S, Wolthoorn J, van Meer G . The cell biology of glycosphingolipids. Semin Cell Dev Biol. 2004; 15(4):375-87. DOI: 10.1016/j.semcdb.2004.03.007. View

11.

Abe A, Inokuchi J, Jimbo M, Shimeno H, NAGAMATSU A, Shayman J . Improved inhibitors of glucosylceramide synthase. J Biochem. 1992; 111(2):191-6. DOI: 10.1093/oxfordjournals.jbchem.a123736. View

12.

Choi M, Maibach H . Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol. 2005; 6(4):215-23. DOI: 10.2165/00128071-200506040-00002. View

13.

Hayashi Y, Horibata Y, Sakaguchi K, Okino N, Ito M . A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates. Anal Biochem. 2005; 345(2):181-6. DOI: 10.1016/j.ab.2005.05.029. View

14.

Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E . Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta. 2006; 1758(12):1864-84. DOI: 10.1016/j.bbamem.2006.08.009. View

15.

Maunula S, Bjorkqvist Y, Peter Slotte J, Ramstedt B . Differences in the domain forming properties of N-palmitoylated neutral glycosphingolipids in bilayer membranes. Biochim Biophys Acta. 2006; 1768(2):336-45. DOI: 10.1016/j.bbamem.2006.09.003. View

16.

Xie P, Shen Y, Shi Y, Ge S, Gu Z, Wang J . Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res. 2007; 32(3):475-80. DOI: 10.1016/j.leukres.2007.07.006. View

17.

Hakomori S . Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta. 2007; 1780(3):325-46. PMC: 2312460. DOI: 10.1016/j.bbagen.2007.08.015. View

18.

Yoshizaki F, Nakayama H, Iwahara C, Takamori K, Ogawa H, Iwabuchi K . Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Biochim Biophys Acta. 2007; 1780(3):383-92. DOI: 10.1016/j.bbagen.2007.11.004. View

19.

Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y . Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie. 2009; 91(6):784-90. DOI: 10.1016/j.biochi.2009.04.001. View

20.

Imokawa G . A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J Dermatol Sci. 2009; 55(1):1-9. DOI: 10.1016/j.jdermsci.2009.04.006. View